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a b s t r a c t
Hepatitis C virus (HCV) induces cytopathic effects in the form of hepatocytes apoptosis thought to be
resulted from the interaction between viral proteins and host factors. Using pathway speciﬁc PCR array,
we identiﬁed 9 apoptosis-related genes that are dysregulated during HCV infection, of which the BH3-
only pro-apoptotic Bcl-2 family protein, BIK, was consistently up-regulated at the mRNA and protein
levels. Depletion of BIK protected host cells from HCV-induced caspase-3/7 activation but not the
inhibitory effect of HCV on cell viability. Furthermore, viral RNA replication and release were
signiﬁcantly suppressed in BIK-depleted cells and over-expression of the RNA-dependent RNA poly-
merase, NS5B, was able to induce BIK expression. Immunoﬂuorescence and co-immunoprecipitation
assays showed co-localization and interaction of BIK and NS5B, suggesting that BIK may be interacting
with the HCV replication complex through NS5B. These results imply that BIK is essential for HCV
replication and that NS5B is able to induce BIK expression.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Initially known as the non-A, non-B hepatitis (NANBH) virus
(Alter et al., 1975), the hepatitis C virus (HCV), which was identiﬁed
in 1989 (Choo et al., 1989; Houghton, 2009), is a single-stranded
positive-sense RNA virus (Choo et al., 1991) classiﬁed as a member
within the Hepacivirus genus in the Flaviviridae family (Drexler et al.,
2013; Lindenbach et al., 2007). With high divergence in sequence due
to the error-prone nature of the viral RNA-dependent RNA polymer-
ase, HCV is classiﬁed into 7 phylogenetic clades designated from
genotype 1 through 7, with more than 30% divergence based on
nucleotide sequences and over 70 subtypes within an individual
genotype (Simmonds, 2013; Simmonds et al., 2005). Chronic HCV
infection is estimated to affect about 170 million people worldwide
or 3% of the world’s population (Lavanchy, 2009). In addition, there
are 3 to 4 million new yearly infected cases coupled with 350,000
patients dying from HCV-related diseases (Shepard et al., 2005;
WHO, 2012). Despite the fact that HCV was identiﬁed over two
decades ago, there is still no therapeutic vaccine for HCV infection
and treatment regimen for chronic infections are limited with
various serious side effects as well as high treatment cost (EASL,
2011; Hayashi and Takehara, 2006). Thus, identiﬁcation and discov-
ery of new, innovative, and effective treatment is highly desirable in
order to curb the spread of HCV.
HCV has a 9.6 kb genome size with an open reading frame (ORF)
ﬂanked by two regulatory un-translated regions (UTR), the 50UTR and
30UTR, respectively (Bostan and Mahmood, 2010). The ORF is trans-
lated into a precursor polyprotein of approximately 3000 residues
which is then co- and post-translationally processed by viral and
cellular proteases into at least three structural proteins (core, E1, and
E2), a small ion channel protein (p7), and six non-structural proteins
(NS2, NS3, NS4A, NS4B, NS5A, and NS5B) (Lin et al., 1994; Lindenbach
et al., 2007).
Although ample studies suggest a strong tie between chronic HCV
infection and liver damage, the mechanisms involved are still not
well established. A combination of viral cytopathic effects (CPE) and
host immune responses are believed to contribute to the liver injury
observed in HCV infection (Guicciardi and Gores, 2005; Park et al.,
2012). While HCV is not a cytolytic virus, studies have demonstrated
that hepatocyte apoptosis plays a major part in the host anti-viral
defense mechanism against HCV as it prevents viral replication as
well as aids in the elimination of virus-infected hepatocytes (Lim
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et al., 2012). Similarly, a number of recent studies using the HCV cell
culture (HCVcc) system (Lindenbach et al., 2005) have shown that
HCV can have direct CPE and induce cell death in the form of
apoptosis in hepatocytes (Deng et al., 2008; Mateu et al., 2008;
Mohd-Ismail et al., 2009; Walters et al., 2009; Zhu et al., 2007). It is
believed that HCV modulates host apoptosis by interacting with a
couple of host factors. Ectopic expression of the individual viral
proteins in cell culture as well as using the subgenomic replicon
system, have shed more light on the contributions of the individual
viral genes to host apoptosis (see review (Aweya and Tan, 2011)). For
instance, using a NS3-5B subgenomic replicon, Lan et al. (2008)
showed that the HCV non-structural proteins are key modulators
which sensitize human hepatoma cells to TRAIL-induced apoptosis.
Similarly, data from our laboratory have previously demonstrated that
the HCV core protein is pro-apoptotic and a novel BH3-only viral
homologue (Mohd-Ismail et al., 2009) while more recent data
demonstrated that the small ion channel protein, p7, induces apop-
tosis in Huh7.5 cells in a caspase-dependent manner involving both
the extrinsic and intrinsic pathways (Aweya et al., 2013). As the
various HCV-encoded proteins play a different role in modulating host
apoptosis by interacting and interfering with different host factors
and/or cellular events, understanding how this intricate host-viral
interaction is regulated so as to prevent premature death of infected
cells and to establish persistent infection would be essential in
understanding the disease pathogenesis and for instituting an effec-
tive treatment regimen.
In this study, we sought to identify the host apoptosis-related
factors that are differentially regulated during HCV infection and
subsequently the viral factor(s) responsible for modulating the host
death response. Using an apoptosis-speciﬁc PCR array, we success-
fully identiﬁed 9 apoptosis-related genes that were differentially
expressed during HCV infection. Of the 9 genes, BIK, a pro-apoptotic
BH3-only protein of the Bcl-2 family, was consistently up-regulated
at both the transcriptional and translational level. Depletion of BIK
using small interfering RNA (siRNA) did not affect the growth of
Huh7.5 cells but signiﬁcantly decreased HCV RNA replication as
well as the viral release indicating the importance of BIK expression
during HCV infection. In addition, by utilizing the lentivirus system,
we showed that transduction of NS5B of genotype 2a (JFH1 strain)
into Huh7.5 is sufﬁcient to induce an up-regulation of BIK. Finally,
using immunoﬂuorescence and co-immunoprecipitation analyses,
we showed the co-localization and interaction of BIK and NS5B in
infected cells, respectively, suggesting that BIK may be recruited or
interacting with the HCV replication complex via NS5B to assist in
the viral replication and release.
Results
Effects of HCV infection on apoptosis-related genes expression
To examine the effects of HCV infection on host apoptosis, the RT²
Proﬁler PCR Array Human Apoptosis platform was used to screen 84
apoptosis-related genes following a 6-day course of infection of
Huh7.5 cells with J6/JFH-1-P47 virus. Samples were collected from
three time points for analysis (2, 4, and 6 d.p.i.). Four independent
experiments were performed and the mean fold change of the mRNA
levels as compared to mock was determined. Genes with Z3 fold
changes and po0.05 at the mRNA level in at least one of the time
points were selected for further veriﬁcation. Upon validation using
TaqMan qPCR, 9 genes were identiﬁed from the data that showed
consistent up- or down-regulation upon HCV infection (Fig. S1).
Using TaqMan qPCR method, we obtained a similar trend, although
in general, a higher fold change in transcript level for most of the
differentially expressed genes, especially at the 6 d.p.i. time point was
observed, indicating that the TaqMan qPCR is more sensitive com-
pared to the SYBR green system (Fig. S1) (Cao and Shockey, 2012).
Further validation using Western blot analysis indicated that BIK
showed consistent up-regulation at the protein level in two of the
three time points that were examined and thus was selected as the
focus of this study. As shown in Fig. 1, a signiﬁcant increase in the
mRNA level of Bikwas observed as early as 2 d.p.i. (Fig. 1A) while the
increase in protein expression was not seen until 4 and 6 d.p.i.
(Fig. 1B). Nevertheless, both qPCR and Western blot analysis sup-
ported the PCR array data where infection with HCV leads to up-
regulation of BIK expression. The tissue culture adapted J6/JFH-1-P47
virus has accumulated several mutations to achieve high infectivity
in tissue culture system (Bungyoku et al., 2009). To determine
whether the up-regulation of BIK is applicable to the parental HCV
strain, a similar 6-day infection course was repeated using the J6/JFH-
1-P1 virus. As shown in Supplementary Fig. 2, the level of BIK was
also increased at both the mRNA and protein levels albeit to a lesser
degree than in the P47-infected cells, with the most signiﬁcant
difference observed during 6 d.p.i. (Fig. S2). As the parental P1 virus is
not tissue culture adapted and does not exert a similar level of CPE in
host cell as the P47 virus, this result is as expected (Deng et al., 2008).
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Fig. 1. Real-time qPCR and Western blot validation of the PCR array data, performed for the expression of BIK following HCV infection. (A) Total RNA from HCV J6/JFH-1-P47-
infected or mock-infected Huh7.5 cells harvested at 2, 4, and 6 d.p.i were used to assess mRNA levels by TaqMan qPCR using speciﬁc primers to Bik and normalized to
endogenous GAPDH. The TaqMan qPCR data (gray bars) shown represent the mean7standard deviation of triplicate wells for four independent experiments. Fold-changes
calculated for the PCR array data, which relied on single wells, hence, standard deviations are not displayed, are also indicated (white bars). p-Values were calculated using
the Student’s T-test with statistical signiﬁcance between mock and infected marked by asterisks (npo0.05 and nnpo0.01). (B) Western blots were probed with human anti-
BIK (top), anti-HCV core (middle), and anti-β-actin (bottom), which was used as a loading control. The Western blots shown represent one of three independent experiments.
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Thus, infection of Huh7.5 cells with HCV induces up-regulation of BIK
independent of the mutations from the tissue culture adaptations in
the J6/JFH-1-P47 virus.
siRNA knockdown of BIK does not affect Huh7.5 viability
To study the functional role of BIK in HCV infection, depletion of
BIK from Huh7.5 cells was performed using siRNA and the effect of
such depletion on the host was examined by determining the cell
viability or proliferation and apoptosis. To obtain sustained knock-
down of BIK expression, 20 nM of siRNA targeting the human Bik
(siBIK) was used to transfect Huh7.5 cells. The level of knockdown
was assessed at 2, 4, 6, and 8 days post-transfection (d.p.t.). As shown
in Fig. 2A, the endogenous BIK level was successfully depleted and
sustained for up to day 8 post-transfection in the siBIK treated cells
as compared to the control siRNA group (siCtrl) (Fig. 2A). Upon
successful knockdown of BIK, cell viability assay was performed at
the indicated time points between siBIK- and siCtrl-treated cells. As
shown in Fig. 2B, the siBIK-mediated depletion of BIK in Huh7.5 cells
did not adversely affect the cell viability across the four measured
time points as both the siCtrl- and siBIK-treated cells had similar
proliferation rates (Fig. 2B). These results suggested that depletion of
endogenous BIK was attainable with 20 nM of siRNA for up to 8 days
without affecting the viability or proliferation of the host cells.
BIK depletion reduced HCV-induced apoptosis
Since BIK is a pro-apoptotic protein, we anticipated that in the
absence of BIK cells would be less susceptible to HCV-induced
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Fig. 2. Sustained siRNA-mediated knockdown of BIK expression in Huh7.5 cells and
effects on cell proliferation. (A) Huh7.5 cells transfected with 20 nM siBIK or siCtrl
were harvested and analyzed by Western blot on 2, 4, 6, and 8 d.p.t using anti-
human BIK antibodies, with the level of endogenous β-actin as control. The
Western blots shown are a representative of three independent experiments.
(B) Huh7.5 cells transfected with 20 nM siBIK or siCtrl were analyzed for cell
proliferation/viability at 2, 4, 6, and 8 d.p.t. The percentage of cell viability on day
2 post-transfection was arbitrarily set at 100% and the percentages of the other
samples relative to day 2 were then determined. Data from three independent
experiments are shown with error bars representing the standard deviation.
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Fig. 3. Apoptosis and proliferation of BIK-depleted Huh7.5 cells infected with HCV J6/JFH1-P47 virus. (A) HCV-infected siBIK or siCtrl transfected Huh7.5 cells were analyzed
by Western blot at 0, 2, 4, and 6 d.p.i using anti-human BIK and anti-HCV core antibodies, with the level of endogenous β-actin as control. The Western blots shown are
representative of three independent experiments. (B) HCV-infected siBIK or siCtrl transfected Huh7.5 cells were analyzed for Caspase-3/7 activation at 0, 2, 4, and 6 d.p.i. The
readings were normalized to cell numbers as determined by the cell viability assay (see C). A representative ﬁgure is shown here with error bars representing the standard
deviation. (C) HCV-infected siBIK or siCtrl transfected Huh7.5 cells were analyzed for cell viability/proliferation at 0, 2, 4, and 6 d.p.i. Readings were normalized to mock-
infected samples, which were arbitrarily set at 100%. A representative data set is shown with error bars representing the standard deviation. p-Values were calculated using
the Student’s T-test with statistical signiﬁcance shown by asterisks (npo0.05 andnnpo0.01).
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apoptosis. To examine the cells’ response to apoptosis stimulus from
HCV infection, siBIK- or siCtrl-treated Huh7.5 cells were infected with
HCV J6/JFH-1-P47 and cell viability assay was performed at 0, 2, 4,
and 6 d.p.i. Immunoblot analysis revealed successful knockdown of
BIK as well as a sustained HCV infection, as indicated by the HCV core
protein level (Fig. 3A). When the caspase-3/7 activity was measured,
as an indication for the induction of apoptosis, HCV infected siBIK-
treated cells showed a signiﬁcantly lower caspase-3/7 activity at
4 and 6 d.p.i. as compared to the infected siCtrl-treated cells (Fig. 3B).
To substantiate our observed attenuated apoptosis induction in siBIK-
treated cells, TUNEL assay was performed to measure the nuclear
DNA fragmentation in the infected cells as an indication for apoptosis
(Gavrieli et al., 1992). Given that the caspase-3/7 activity assay was
only signiﬁcant on 4 and 6 d.p.i. (Fig. 3B), the TUNEL assay was
performed for these two time points. As seen in Supplementary
Fig. 3, there were more TUNEL positive cells in the HCV-infected
siCtrl-treated cells than the HCV-infected siBIK-tread cells (Fig. S3),
which further corroborated the caspase-3/7 (Fig. 3B) results that BIK-
depleted Huh7.5 cells were less susceptible to HCV-induced apopto-
sis. Interestingly, when cell viability test was performed, depletion of
BIK did not signiﬁcantly affect the proliferation of Huh7.5 cells
infected with HCV, as both HCV-infected siBIK- and siCtrl-treated
cells had similar cell viability with proliferation rate progressively
inhibited to the same extent by HCV infection when compared to
their corresponding mock-infected cells (Fig. 3C). Even though the
infected siBIK-treated cells had a reduced level of apoptosis (Fig. 3A,
Fig. S3), their viability and proliferation remained unchanged as
compared to the siCtrl-treated group.
BIK depletion attenuated HCV replication and viral release
To determine the functional signiﬁcance of BIK on HCV, qPCR
and IFA were used to examine the effect of BIK knockdown on HCV
replication as well as viral release. Huh7.5 cells were transfected
with either siCtrl or siBIK and on 2 d.p.t. HCV infection was per-
formed at MOI of 2 for another 6 days. Data analysis from the qPCR
assay showed a signiﬁcant decrease in the level of HCV RNA repli-
cation in the infected siBIK-treated cells as compared to the
infected siCtrl-treated cells (Fig. 4A) on 4 and 6 d.p.i., indicating
that BIK is essential for HCV replication in the host cells. A similar
inhibitory effect, although not as drastic, was also observed at the
protein level as shown in Fig. 3A. Reduction in the HCV core
protein level in the siBIK-treated cells was observed especially on
6 d.p.i. (54% of the siCtrl sample) where the decrease in HCV RNA
level was most signiﬁcant (Fig. 4A). When the release of viral
particles was examined using IFA, the number of infectious HCV
particles released from the siBIK-treated cells was signiﬁcantly
lower on 4 and 6 d.p.i. when compared to the siCtrl-treated group
(Fig. 4B). However, the reduction in viral release, although statis-
tically signiﬁcant, was not as drastic as compared to the decrease
in viral RNA replication (Fig. 4A), as only less than 1log decrease
was observed in the viral release results. This discrepancy has
been observed by others as well where the amount of viral RNA
does not always correlate with the number of infectious viral
particles released into the supernatant (Park et al., 2013). None-
theless, our results still support the fact that BIK depletion affects
HCV RNA replication and the release of infectious HCV particles
into the culture supernatant even though the effect on the latter
was not that drastic.
NS5B induces an increase in BIK expression in Huh7.5 cells
HCV encodes more than 10 viral proteins that have been reported
to exhibit either pro- or anti-apoptotic, or both properties depending
on the experimental design (see review (Aweya and Tan, 2011)).
Preliminary screening from our laboratory suggested that ectopic
over-expression of NS5B via transient transfection in Huh7.5 cells led
to increase BIK mRNA level (Fig. S4). In order to conﬁrm this
observation, lentivirus packaging the HCV NS5B gene was generated
and used to transduce Huh7.5 cells. Samples collected at 72 and 96 h
post-transduction showed that NS5B-transduced cells contained
higher level of BIK at both the transcriptional (Fig. 5A) and transla-
tional stages (Fig. 5B) for both time points as compared to the control
vector-transduced sample. Samples from both the control vector- and
NS5B-transduced cells were also probed with anti-GFP antibody to
conﬁrm the integration and transient expression of the EmGFP gene
from the pLenti7.3 vector (Fig. 5B). This result indicated that HCV
NS5B protein alone can induce BIK expression in Huh7.5 cells. To
determine whether NS5B can induce apoptosis and thus indirectly
induce BIK expression, the caspase-3/7 activity was examined in both
the control vector- and NS5B-transduced samples at 4 different time
points. As shown in supplementary Fig. 5, the caspase-3/7 activity
was similar in both sets of samples across all four time points,
suggesting that NS5B did not indirectly induce the expression of BIK
by activating apoptosis (Fig. S5).
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Fig. 4. HCV replication and release of infectious viral particles into culture supernatant (B) HCV-infected siBIK or siCtrl transfected Huh7.5 cells were harvested at 2, 4, and
6 d.p.i, and analyzed for HCV replication using quantitative real-time PCR analysis and normalized to endogenous GAPDH. At least three independent experiments were
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Co-localization and interaction of BIK and NS5B during HCV infection
Thus far, our results suggested that BIK is functionally signiﬁcant
for optimal replication of HCV in Huh7.5 cells (Fig. 4). The fact that
NS5B alone is sufﬁcient to up-regulate BIK expression in Huh7.5
cells (Fig. 5) led us to speculate whether NS5B interacts with BIK or
both were localized within the same compartment to allow for an
interaction. To ascertain this, immunoﬂuorescence analysis were
performed so as to determine the localization of BIK and NS5B
during HCV infection. Confocal images revealed that both BIK and
NS5B co-localized in the ER of HCV-infected Huh7.5 cells (Fig. 6)
conﬁrming our speculation that NS5B maybe recruiting or interacting
with BIK at the replication complex in the ER to assist in HCV repli-
cation. To conﬁrm a possible interaction between NS5B and BIK,
co-immunoprecipitation (Co-IP) analysis was performed using mock
and P47-infected Huh7.5 cell lysate with NS5B antibody. As shown in
Fig. 7A, NS5B protein is only present in the P47-infected cell lysate
and the level of BIK was increased in the infected sample (Fig. 7A).
Using anti-NS5B antibody, BIK was successfully precipitated from the
P47-infected cell lysate while absent in the mock lysate (Fig. 7B). To
rule out the possibility of BIK unspeciﬁcally binding to the protein A
beads or the antibody, 1A9, a species matched non-related antibody
against SARS spike protein (Ng et al., 2014), was used as a negative
control. Our results thus showed positive co-precipitation of BIK with
NS5B antibody and not with the control antibody (Fig. 7B). Hence,
both the immunoﬂuorescence and Co-IP data conﬁrmed that BIK
interacts physically with NS5B and possibly the HCV replication
complex.
Discussion
The molecular characterization of the factors important in HCV
infection and HCV-induced apoptosis is not only important in under-
standing the mechanisms and pathogenesis of the disease but also to
provide new targets in the development of novel antiviral therapies.
For HCV-induced apoptosis, both host and viral factors have been
implicated, however, the molecular mechanisms and the speciﬁc
factor(s) which perpetuate this process remains largely unknown.
The Bcl-2 family members are the major molecular players in
programmed cell death (Edlich et al., 2011; Hardwick and Soane,
2013), with some BH3-only proteins reported to play a role in HCV
infection (Simonin et al., 2009). The BH3-only pro-apoptotic members,
which are the allosteric regulators of the Bcl-2 family members, are
known to bind strongly to the pro-survival members through their
BH3 domains thereby antagonizing their pro-survival function (Chen
et al., 2005). HCV infection has been shown to activate apoptosis
through the induction of cell-death related genes and caspase activa-
tion (see review (Aweya and Tan, 2011)). Using gene proﬁling analysis,
Walters et al. (2009) revealed that the induction of apoptosis-related
genes was linked to the viral load and that this induction of apoptosis
was in response to the cell cycle arrest caused by the HCV infection.
Among the apoptosis-related genes identiﬁed was the Bcl-2 family
BH3-only protein, NBK/BIK, the gene of interest in this study that was
also identiﬁed in our PCR array analysis (Fig. 1). An elevation of BIK
expression has been reported in a number of viral infections including
HCV infection (Chinnadurai et al., 2008; Subramanian et al., 2007;
Walters et al., 2009). However, the functional signiﬁcance and the
molecular mechanisms leading to the up-regulation of BIK expression
in HCV infection remain unexplored.
In this study, pathway focused PCR array analysis was ﬁrst used
to screen for apoptosis-related genes that are dysregulated during
HCV infection. After validation using qPCR (Fig. S1) and Western blot
analysis (data not shown), only the differential expression of BIK was
found to be consistently up-regulated at both the transcriptional and
translational levels (Fig. 1). Most importantly, we showed that the
up-regulation of BIK in HCV J6/JFH-1-P47 infection is not a conse-
quence of the mutations accumulated in this tissue culture adapted
virus as induction of BIK expression was also observed in cells
infected with the parental HCV J6/JFH-1-P1 virus (Fig. S2).
In order to decipher the role of BIK in HCV infection, depletion of
BIK was performed using RNAi system. As BIK is a pro-apoptotic
protein, in the absence of it, cells are expected to be less susceptible
to apoptosis stimulus. As expected, the level of apoptosis induced in
the form of caspase-3/7 activation and DNA fragmentation (TUNEL
positive cells) was signiﬁcantly higher in the HCV-infected control
cells than in the HCV-infected BIK-depleted cells (Fig. 3B and Fig. S3).
Our observation is in accordance with studies from other groups
examining the effect of BIK knockdown and apoptosis, where BIK-
depleted cells were more resistant to apoptosis induced by various
agents (Fu et al., 2007; Hur et al., 2006; Li et al., 2008; Mebratu et al.,
2008; Shimazu et al., 2007; Viedma-Rodriguez et al., 2013). In terms
of viral induced apoptosis and BIK expression, our observation is in
accordance with these studies.
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When the effects of BIK depletion on the host cell following HCV
infectionwas examined, no signiﬁcant difference was observed in the
cell viability between the infected BIK-depleted and the control cells,
as the proliferation of both infected groups were inhibited to
the same extent by HCV relative to the mock (Fig. 3C). A similar
observation was made by Urban et al. (2008) where they reported
that mouse embryonic ﬁbroblasts (MEFs) deﬁcient in a number of
BH3-only proteins, including Bim, Bik, Bmf, BAD, Puma, Noxa or a
combination of Bim and BAD (Bim/BAD DKO), died in response to
Semliki Forest virus (SFV) infection in a similar manner as wild-type
MEFs. This thus gives us quite an intriguing contrast because, while
the loss of pro-apoptotic BIK protected against HCV-induced apop-
tosis, there was no signiﬁcant effect on the cell viability upon HCV
infection (Fig. 3B). A couple of reasons could account for this unusual
dichotomy. First, it has been demonstrated that there is a diversion of
cells to autophagic cell death when there is deﬁciency or block in
apoptosis (Rashmi et al., 2008). Thus, it is probable that the decrease
in apoptosis in the HCV-infected BIK-depleted cells is compensated
for by an increase in autophagic or other forms of cell death. Recent
studies have identiﬁed that the Bcl-2 binding partner, Beclin-1 may
serve as a link for the crosstalk between the apoptotic and autopha-
gic signaling pathways (see review Gordy and He, 2012). Pattingre
et al. (2005) showed that one way of regulating autophagy activation
is by sequestering the key inducer of autophagy, Beclin-1, by the Bcl-
2 family proteins. A more recent study reported that BCLAF1, a Bcl-2
interacting protein, induces autophagic cell death in myeloma cells
by displacing Beclin-1 from Bcl-2 protein (Lamy et al., 2013). Our PCR
array screening identiﬁed BCLAF1 as one of the genes that were up-
regulated during HCV infection and was also validated by TaqMan
qPCR (Fig. S1). In the absence of BIK, the increased BCLAF1 expression
could in turn activate the autophagic cell death pathway which could
possibly explain why the absence of BIK did not have an impact on
cell viability (Fig. 3C) despite a signiﬁcant decrease in apoptosis
induction (Fig. 3B, Fig. S3). In addition, the functional redundancy
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Fig. 6. BIK and NS5B co-localize within the ER in HCV infected Huh7.5 cells. Immunoﬂuorescence analysis was performed on HCV-infected Huh7.5 cells using antibodies
against BIK, NS5B, and ER markers (calreticulin and calnexin). Nuclei were counterstained with DAPI (blue). Three independent experiments were performed with a
representative set of images shown here.
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within the BH3-only proteins (Bouillet and Strasser, 2002; Coultas et
al., 2004; Happo et al., 2012; Villunger et al., 2003) could also be
accountable for the lack of effect of BIK depletion on cell viability in
HCV-infected cells.
Viral replication is generally affected by the ability of the virus to
counteract pro-apoptotic signals induced by host cells, since pre-
mature cell death of infected cells would prevent the production of
progeny virions. It is therefore expected that in the absence of pro-
apoptotic BIK, viral replication will be enhanced. Interestingly, BIK-
knockdown suppresses HCV RNA replication (40% to 50% cf. control)
and production of HCV particles (ca. 65% cf. control), suggesting the
possible role of BIK in HCV RNA replication (Fig. 4). In order to under-
stand which step in the virus life-cycle that BIK could be involved in,
the effects of individual viral proteins on the expression of BIK were
determined. Our results show that the expression of NS5B alone is
sufﬁcient to increase Bik expression at both the mRNA and protein
levels (Fig. 5). So what is the functional signiﬁcance of BIK up-
regulation during HCV infection? The HCV replication complex is in
the endoplasmic reticulum (ER) (El-Hage and Luo, 2003) where BIK is
known to be localized (Mathai et al., 2002). Immunoﬂuorescence
analysis revealed that in HCV-infected Huh7.5 cells both BIK and NS5B
are localized in the same compartment within the ER (Fig. 6). Further
analysis using Co-IP showed a positive interaction between BIK and
NS5B (Fig. 7B). This raises some further interesting questions as to
whether NS5B is involved in the recruitment of BIK to the replication
complex to assist in HCV replication. Interestingly, several critical
interactions between cellular factors and the replication complex of
HCV have been reported. For example, HCV NS5A has been shown to
speciﬁcally interact with the host cell protein TBC1D20 (a Rab1
GTPase-activating protein), depletion of which severely impaired
HCV replication and prevented the accumulation of viral RNA (Sklan
et al., 2007). Similarly, the interaction of HCV NS4B with Rab5 (also a
Rab GTPase) was demonstrated to be crucial for HCV replication
(Manna et al., 2010; Stone et al., 2007).
Taken together, our present results suggest that BIK is highly up-
regulated during HCV infection and to a lesser extent, by NS5B alone.
BIK-depleted Huh7.5 cells are protected against HCV-induced cas-
pase-dependent apoptosis, but did not protect the cells against the
inhibitory effects of HCV infection on cell viability. More importantly,
the data suggest that BIK is essential for HCV RNA replication and
viral release as knockdown of BIK signiﬁcantly affected HCV viral
replication and release. BIK is therefore an important host factor that
plays a vital role in the host cells’ response to HCV infection and may
inﬂuence some aspects of the viral life cycle independent of its role
in regulating apoptosis during infection. Lastly, both BIK and NS5B
are shown to interact as well as co-localized in the same compart-
ment within the ER where the HCV replication complex occurs. It is
therefore conceivable to postulate that the interaction between BIK
and NS5B in the replication complex is essential for HCV replication.
Future work would be done to substantiate this hypothesis.
Materials and methods
Cell lines and reagents
Huh7.5 cells (subclone of the Huh-7 human hepatoma cell line;
Apath, Brooklyn, NY) and 293FT cells (human embryonic kidney
cell line with the temperature sensitive gene for SV40 T-antigen;
Invitrogen, Karlsruhe, Germany) were grown in Dulbecco’s mod-
iﬁed Eagle’s medium (DMEM) (Invitrogen, Carlsbad, CA) supple-
mented with 10% fetal bovine serum (HyClone, Utah, USA), 0.1 mM
nonessential amino acids, and antibiotics (10 units/ml penicillin
and 10 μg/ml streptomycin) (Invitrogen). All cells were maintained
in a 37 1C incubator with 5% CO2.
Viruses
HCV J6/JFH-1-P47 virus (Bungyoku et al., 2009), which is a tissue
culture adapted strain of the J6/JFH-1 chimeric virus that possesses
enhanced infectivity, was used in majority of the experiments. The
adapted virus was obtained by passaging J6/JFH-1-infected cells 47
times and contains 10 amino acid mutations (K78E, T396A, T416A,
N534H, A712V, Y852H, W879R, F2281L, M2876L and T2925A) and a
single nucleotide mutation in the 50-UTR (U146A). For the generation
of the parental J6/JFH-1-P1 virus (P1 virus), full-length viral RNA was
in vitro transcribed using MEGAscript T7 kit (Ambion, Austin, TX) and
electroporated into Huh7.5 cells as described (Kato et al., 2006).
Supernatant containing P1 virus was further concentrated 10-fold
using Amicon Ultra-15 Centrifugal Filter Units with 100 kDa cut off
(EMD Millipore Corporation, Billerica, MA) and stored at 80 1C.
Lentivirus used in the transduction assay was generated using
the ViraPower HiPerform Lentiviral Expression Systems (Invitro-
gen) by cloning the full length NS5B ampliﬁed from the parental
J6/JFH-1 plasmid into the pLenti7.3/V5-TOPO vector. pLenti7.3/V5-
GW/lacZ provided in the kit was used as control vector for
transduction. Lentivirus packaging the gene of interest or the
control vector were generated in 293FT cells following the man-
ufacturer’s instruction.
Generation of anti-NS5B monoclonal antibody
The cDNA encoding for the N-terminal fragment (residues 1 to 385)
of NS5B of JFH-1 HCV was cloned into the pGEX-6P1 vector (GE
Healthcare, Uppsala, Sweden). Glutathione S-transferease (GST)-fusion
NS5B protein was then expressed in Escherichia coli BL21(DE3) (Nova-
gen, EMD Chemicals, Inc., Madison, WI) and puriﬁed as previously
described (Tan et al., 2010). The GST-fusion protein was then used to
immunize mice and generate hybridomas as previously described (Oh
et al., 2010). All mice were handled according to National Advisory
Committee for Laboratory Animal Research (NACLAR) guidelines.
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Fig. 7. Co-immunoprecipitation (IP) of BIK with NS5B. Cell lysates from mock and P47-infected Huh7.5 were prepared and subjected to Co-IP using antibody against NS5B
and a control antibody of the same species, anti- SARS spike protein. (A) Cell lysates and (B) Co-IP products were analyzed via Western blot and probed with antibodies
against BIK. β actin was used as loading control.
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SDS-PAGE and immunobloting
Proteins were separated by SDS-PAGE and transferred to nitro-
cellulose or PVDF membranes using wet transfer. Following transfer,
membranes were blocked in 5% (w/v) skimmed milk powder, 0.1%
(v/v) Tween20 in Tris-Buffered Saline (TBS) (blocking buffer), and
incubated with the appropriate primary and secondary antibodies.
The primary antibodies used in this study include: homemade anti-
HCV NS5B monoclonal, anti-β-actin monoclonal, anti-BIK (NBK)
polyclonal (Santa Cruz Biotechnology, Santa Cruz, CA), anti-HCV
core monoclonal (Pierce/Thermo scientiﬁc, Rockford, IL), and anti-
GFP monoclonal (Roche, Indianapolis, IN) antibodies. Secondary
antibodies used include: horseradish peroxidase (HRP)-conjugated
goat anti-mouse and rabbit anti-goat antibodies (Pierce, Rockford,
IL). Protein bands were visualized by enhanced chemiluminescence
(ECL) according to the manufacturer’s protocol.
HCV infection
Monolayers of Huh7.5 cells plated at a density of 6105 cells
(6 cm dish), 6104 cells (12-well plate), 3104 cells (24-well
plate), or 1104 cells (96-well plate), were infected with the virus
suspended in DMEM (plus 10% FBS) at a multiplicity of infection
(MOI) of 2. The virus was allowed to bind for 5–6 h at 37 1C in a 5%
CO2 incubator, after which the inoculum was removed and the
cells were replenished with fresh growth media without antibio-
tics and incubated further under the same conditions until harvest.
Virus titration
Virus infectivity was measured by indirect immunoﬂuores-
cence analysis (IFA) as described (Deng et al., 2008). Brieﬂy, culture
supernatants containing HCV were serially diluted 10-fold in
complete DMEM and used to infect 1.9105 Huh7.5 cells seeded
on glass coverslips in a 24-well plate. The inoculum was incubated
with cells for 5 h at 37 1C and then replaced with fresh complete
DMEM. IFA was performed at 24 h post-infection as described
above using anti-NS5B antibodies generated in the lab and Alexa-
Fluor 488 goat anti-mouse IgG antibody (Invitrogen).
Lentivirus was titrated using qPCR method as described (Lizee
et al., 2003). Primer sequences were adapted from the same paper,
WPRE for lentivirus-speciﬁc primers and albumin for host-speciﬁc
gene and the corresponding TaqMan probes were synthesized by
Integrated DNA Technology (IDT, Coralville, IA),. Brieﬂy, culture
supernatants containing lentivirus were serially diluted 10-fold in
complete DMEM and used to transduce 1105 Huh7.5 cells
seeded in 12-well plate in the presence of 10 μg/ml of polybrene.
After 6 h, supernatant was replaced with fresh complete DMEM
and cell genomic DNA was harvested at 72 h post-transduction
using DNeasy Blood & Tissue Kit (Qiagen, Valencia, CA) following
the manufacturer’s instruction. qPCR was performed as described
(Lizee et al., 2003) and standard curve was generated using ten-
fold serial dilutions of known concentration of plasmid constructs
containing either WPRE or albumin sequences for quantiﬁcation of
unknown samples.
Small interfering RNA (siRNA)-mediated gene silencing
A 21-nucleotide RNA duplex targeting the coding region of
human BIK gene (Hur et al., 2004) was purchased from Thermo
Scientiﬁc Dharmacon (Dharmacon, Lafayette, CO). The siRNA
sequences were as follows: 50-GACCCCUCUCCAGAGACAUUU-30
(sense) and 50-AUGUCUCUGGAGAGGGGUCUU-30 (antisense). The
lyophilized siRNAs were reconstituted in RNase-free water to a
ﬁnal concentration of 20 μM. Control siRNA (an irrelevant siRNA
targeting SARS-CoV polymerase) were transfected in parallel to
serve as control. The siRNA transfection was performed using
Lipofectamine RNAiMAX reagent (Invitrogen) according to the
manufacturer’s recommendations. Brieﬂy, Huh7.5 cells were pla-
ted in antibiotic-free media at a density of 3105 cells and when
50% conﬂuent, the cells were transfected with 20 nM of BIK siRNA
or control siRNA. At 24 h post-transfection, the siRNA transfec-
tion media was removed and the cells were replenished with
antibiotic-free media. Cells were harvested at 2, 4, 6, and 8 days
post-transfection and the knockdown efﬁciency was examined by
immunoblot analysis.
Isolation of total cellular RNA and reverse transcription
Total RNA from Huh7.5 cells in 24-well plates infected with the
J6/JFH1 virus or mock treated was isolated at 2, 4, and 6 days post-
infection (d.p.i.). Following removal of culture medium, the cells
were rinsed twice in PBS and RNA was extracted using an RNeasy
Mini Kit with an on-column DNase treatment step (Qiagen)
according to the manufacturer’s protocol. Total RNA was reverse
transcribed using the QuantiTect Reverse Transcription (RT) kit
(Qiagen). For PCR array analysis, total RNA was reverse transcribed
into cDNA using the RT2 First Strand Kit (SABiosciences, Frederick,
MD) according to the manufacturer’s instructions.
Gene expression proﬁling using PCR arrays
Template cDNA was mixed with RT2 SYBR Green/ROX qPCR
master mix (SABiosciences) and 25 μl of this mixture was added to
each well of the 96-well PCR array containing speciﬁc primer sets.
The Human Apoptosis RT2 Proﬁler PCR Array (SABiosciences) exam-
ines 84 genes involved in the apoptotic pathway. These genes include
members of the caspase, Bcl-2, IAP, TRAF, CARD, CIDE, death domain,
death effector domain, and TNF receptor and ligand families, as well
as genes involved in the p53 and DNA damage pathways. The array
also contains primer sets for ﬁve housekeeping genes and three RNA
and PCR quality controls. The PCR cycling program was performed
using an ABI 7900HT Fast Real-Time PCR System (Applied Biosys-
tems, Foster City, CA). Expression proﬁles of HCV-infected and mock-
treated cells at the different time points were obtained from four
independent experiments. The threshold cycle (Ct) values of each
gene were used to calculate the fold changes in gene expression
using the RT2 Proﬁler PCR Array Data Analysis software (http://
pcrdataanalysis.sabiosciences.com/pcr/arrayanalysis.php).
Quantitative real-time PCR
Gene expression changes observed with the PCR arrays were
conﬁrmed by quantitative real-time PCR using TaqMan chemistry.
Probes and primers speciﬁc to the host genes that were identiﬁed by
the PCR arrays to be up- or down-regulated in response to HCV
infection were obtained from Applied Biosystems (Applied Biosys-
tems). GAPDH was selected as the reference gene for normalization.
Each reaction was performed in triplicates and no template controls
were included for each primer/probe set. Ampliﬁcation was mon-
itored on an ABI 7900HT Fast Real-Time PCR System (Applied
Biosystems). The difference in Ct values (ΔCt) between the gene of
interest and GAPDH control was used to calculate the fold changes in
gene expression (2ΔΔCt) between HCV-infected and mock-infected
Huh7.5 cells. Results were pooled from at least three independent
experiments.
Viral RNA quantiﬁcation
To measure the intracellular HCV RNA replication levels, cDNA
was subjected to quantitative real-time PCR analysis using the
SYBR Green-based detection system. The primer sequences are as
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follows: HCV primers (NS5A) 50-AGA CGT ATT GAG GTC CAT GC-30
(sense) 50-CCG CAG CGA CGG TGC TGA TAG-30 (antisense), GAPDH
primers 50-CAT GAG AAG TAT GAC AAC AGC CT-30 (sense), 50-AGT
CCT TCC ACG ATA CCA AAG T-30 (antisense). HCV and GAPDH
transcript levels were determined relative to standard curves
derived from serial dilutions of plasmids containing either the
HCV J6/JFH-1 cDNA or the human GAPDH gene.
Lentivirus transduction
6104 of Huh7.5 cells were seeded in 12-well plate 24 h before
transduction. Lentiviral particles packaging either the control
vector or NS5B were used to transduce Huh7.5 cells at 0.1 TU/cell
in the presence of 10 μg/ml of polybrene. Cells were harvested for
RNA extraction and immunoblot analysis at 72 and 96 h post-
transduction.
Cell viability assay
The viability of the cells was determined using the CellTiter-
Blues Cell Viability Assay (Promega, Madison, WI) which provides
a homogeneous, ﬂuorescent method for monitoring cell viability
according to the manufacturer’s instructions. Brieﬂy, Huh7.5 cells
were seeded in 96-well culture plates at a density of 1104 cells
per well. After 24 h, the cells were infected with an appropriate
MOI of HCV J6/JFH-1-P47. At speciﬁc time points post-infection,
the CellTitre-Blue reagent was diluted (1:4) with PBS and added to
each well, mixed for 2 min on an orbital shaker and incubated at
37 1C for 2 h. The ﬂuorescence readings were measured at 570 nm
using Tecan M200 microplate reader (Tecan Trading AG, Switzer-
land). Relative cell number was calculated by normalizing the
absorbance to untreated cells. Relative cell viability was compared
to untreated cells.
TUNEL assay
The Terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL) assay was carried out using the DeadEnd Fluoro-
metric TUNEL system (Promega) according to the manufacturer’s
protocol. Brieﬂy, Huh7.5 cells were plated onto 4-well chamber
slides (Lab-Tek™) at a density of 1104 cells per well, infected
with HCV J6/JFH-1-P47. At the indicated time point post-infection,
cells were ﬁxed in 4% paraformaldehyde at 4 1C for 25 min. Fixed
cells were then permeabilized in 0.1% Triton X-100 and labeled
with ﬂuorescein-12-dUTP using terminal deoxynucleotidyl trans-
ferase. After washing with 1X PBS, slides were mounted with
VECTASHIELDsmounting mediumwith DAPI (Vector Laboratories,
Burlingame, CA). The TUNEL-positive cells (bright green spots)
corresponding to the nuclei location (DAPI) were captured with
Olympus FluoView FV1000 (Olympus, Japan) laser scanning con-
focal microscope using a 60 /1.45 oil objective, with 543 nm
HeNe laser as the excitation source.
Caspase enzymatic activities
The activation of caspase-3/7, a hallmark of apoptosis, was
measured using the Caspase-Glo 3/7 luminescent assay system
(Promega) according to the manufacturer’s instructions. An equal
volume of Caspase-Glo reagent, which contains cell lysis buffer and
luminogenic substrate containing the caspase-3 cleavage site tetra-
peptide sequence DEVD, was added to cells cultured in an opaque
96-well microplate. The plate was incubated at room temperature
for 2 h. Caspase cleavage of the substrate releases aminoluciferin
and the amount of luminescence produced is proportional to the
amount of caspase activity present in the sample. Luminescence
was measured in relative light units (RLU) using a Tecan M200
microplate reader (Tecan).
Immunoﬂuorescence assay (IFA)
For indirect immunoﬂuorescence staining, transfected Huh
7.5 cells grown on coverslips were ﬁxed with 4% paraformaldehyde
for 15 min. Fixed cells were permeabilized with 0.1% Triton X-100 in
PBS for 15 min, blocked with 1% bovine serum albumin (BSA) in PBS
for 30 min and incubated with primary antibodies (ER-markers,
anti-BIK, or anti-NS5B) for 1 h. For cells incubated with anti-BIK
antibodies, after several washes, cells were ﬁrst incubated with
Alexa-Fluor-546-conjugated donkey anti-goat IgG for 1 h. After
three 10 minwashes with blocking buffer, cells were then incubated
with Alexa-Fluor-488-conjugated goat anti-mouse IgG secondary
antibodies or Alexa-Fluor-488-conjugated goat anti-rabbit IgG sec-
ondary antibodies (Invitrogen) for 1 h. The washed coverslips were
then counter stained with 40,6-diamidino-2-phenylindole (DAPI)
and mounted on glass microscope slides using Fluorsave mounting
medium (Calbiochem, Merck KGaA, Darmstadt, Germany). Images
were captured with Olympus FluoView FV1000 (Olympus, Japan)
laser scanning confocal microscope using 100 with 2 zoom oil
objective, with 543 nm HeNe laser as the excitation source.
Co-immunoprecipitation (Co-IP)
Huh7.5 cells were infected with P47 virus at 2MOI. Cells were
harvested at 2 d.p.i. and lysed using RIPA buffer (150 mM Tris–HCl,
pH8.0, 250 mM NaCl, 0.5% NP40, 0.5% Sodium deoxycholate,
0.005% SDS). 100 mg of lysates were incubated with 1 mg of
antibodies and 50 ml of Protein A agarose (Roche) at 4 1C on a
nutator. After an overnight incubation, samples were washed at
least 3 times with RIPA buffer at 3000 rpm, 4 1C. During the ﬁnal
wash, 15 ml of 2X SDS dye was added to the beads and samples
were boiled at 100 1C for 15 min prior to analysis using SD-PAGE
and Western blot.
Statistical analysis
Statistical tests were mostly performed using Microsoft Excel
and the RT2 Proﬁler PCR Array Data Analysis software in the case
of PCR array data. All experiments were repeated at least three
times. Statistical analysis was performed using the Student’s
T-test. po0.05 was considered signiﬁcant. The relevant tests and
level of signiﬁcance are noted in the ﬁgure legends.
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